AGR2 | Anterior gradient 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
BCL2L14 | BCL2-like 14 (apoptosis facilitator) | Predicted intracellular proteins
| | | | | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C9orf152 | Chromosome 9 open reading frame 152 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CAPN9 | Calpain 9 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CES3 | Carboxylesterase 3 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EYS | Eyes shut homolog (Drosophila) | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
FERMT1 | Fermitin family member 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
FXYD3 | FXYD domain containing ion transport regulator 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GALNT5 | Polypeptide N-acetylgalactosaminyltransferase 5 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
KRT20 | Keratin 20 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MCOLN2 | Mucolipin 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
NOXO1 | NADPH oxidase organizer 1 | FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PAX4 | Paired box 4 | Disease related genes Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
PPP1R1B | Protein phosphatase 1, regulatory (inhibitor) subunit 1B | Predicted intracellular proteins
| | | | | Tissue enhanced |
PTPRO | Protein tyrosine phosphatase, receptor type, O | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SAMD13 | Sterile alpha motif domain containing 13 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
TFF3 | Trefoil factor 3 (intestinal) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TSPAN8 | Tetraspanin 8 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ZG16 | Zymogen granule protein 16 | Predicted secreted proteins
| | | | | Tissue enhanced |